Evidence map›Paper›PMID 40794555›Full record

ArticleBrain : a journal of neurology2025

Deep learning-based cell type profiles reveal signatures of Alzheimer's disease resilience and resistance.

Eloise Berson, Amalia Perna, Syed Bukhari, Yeasul Kim, Lei Xue, David Seong, Samson Mataraso, Marc Ghanem, Alan L Chang, Kathleen S Montine and 4 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Decoding Alzheimer's Disease One Cell Class at a Time.Cellular and molecular neurobiology · 2026
    Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Eloise BersonDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Amalia PernaDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Syed BukhariDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Yeasul KimDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94305, USA.
Lei XueDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94305, USA.
David SeongDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94305, USA.
Samson MatarasoDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94305, USA.
Marc GhanemDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94305, USA.
Alan L ChangDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94305, USA.
Kathleen S MontineDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
C Dirk KeeneDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA.
Maya KasowskiDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.
Nima AghaeepourDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-6117-8764
Thomas J MontineDepartment of Pathology, Stanford University, Stanford, CA 94305, USA.

Funding

University of Washington Alzheimer's Disease Research CenterP30AG066509 · NIA · UNIVERSITY OF WASHINGTON · PI Amanda D. Boyd · 2020 to 2026
$29.0M
Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologiesU01AG072573 · NIA · STANFORD UNIVERSITY · PI KUNDAJE, ANSHUL, MONTGOMERY, STEPHEN · 2021 to 2025
$8.3M
Machine Learning for Integrative Modeling of the Immune System in Clinical SettingsR35GM138353 · NIGMS · STANFORD UNIVERSITY · PI AGHAEEPOUR, NIMA · 2020 to 2024
$2.2M
Neuropathology of synapses in AD and ADRDRF1AG077443 · NIA · STANFORD UNIVERSITY · PI AGHAEEPOUR, NIMA, MONTINE, THOMAS J · 2023 to 2023
$2.2M
Neuropathology of synapses in AD and ADRDR01AG077443 · NIA · STANFORD UNIVERSITY · PI Nima Aghaeepour, Thomas J Montine · 2026 to 2026
$707k
NIA NIH HHS P30 AG066509NIA NIH HHS R01 AG077443NIA NIH HHS RF1 AG077443NIA NIH HHS U01 AG072573NIGMS NIH HHS R35 GM138353NIH HHS AG072573NIH HHS AG077443NIH HHS R35GM138353Phil & Penny Knight Initiative for Brain Resilience at the Wu Tsai Neurosciences Institute, Stanford UniversityStanford Bio-X Interdisciplinary Initiatives Seed Grants Program R11-74
6 · The paper itself

Abstract

Neurological disorders result from the complex and poorly understood contributions of many cell types. It is therefore essential to uncover mechanisms behind these disorders and identify specific therapeutic targets. Single-nucleus technologies have advanced brain disease research, but remain limited by their low nuclear transcriptional coverage, high cost and technical complexity. To address this, we applied a transformer-based deep learning model that restores cell type-specific investigation transcriptional programs from bulk RNA sequencing, significantly outperforming previous methods. This enables large-scale and cost-effective investigation of cell type-specific transcriptomes in complex and heterogeneous phenotypes such as cognitive resilience or brain resistance to Alzheimer's disease. Our analysis identified astrocytes as the major cell mediator of Alzheimer's disease resilience across cerebral cortex regions, while excitatory neurons and oligodendrocyte progenitor cells emerged as the major cell mediators of resistance, maintaining synaptic function and preserving neuron health. Finally, we show that our approach could restore the whole tissue transcriptome, offering an unbiased framework for exploring cell-specific functions beyond single-nucleus data.

Indexed as

Alzheimer DiseaseDeep LearningAnimalsAstrocytesCerebral CortexHumansNeuronsTranscriptomeAlzheimer’s disease resilienceAlzheimer’s disease resistancecell type deconvolutionmachine learning

Identifiers

PMID40794555
PMCPMC12404794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.